Drug
Fexinidazole clinical trials
How studies write it
Studies that test it under each name
Name
- Fexinidazole
- 10
Studies by the year they started
11 studies that test it; most in 2014 (3)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 10
Studies
Open first, then newest update. How each study uses fexinidazole is read from its arms, and is right about nine times in ten.
Testing it · 11
- A Pharmacokinetic and Tolerability Study of Fexinidazole in a Single Oral Dose in Adult Participants With Mild and Moderate Hepatic ImpairmentCompletedPhase 1SanofiNCT05607173Written as Fexinidazole (HOE239)
- Fexinidazole in Human African Trypanosomiasis Due to T. b. RhodesienseCompletedPhase 2/3Drugs for Neglected DiseasesNCT03974178Written as Fexinidazole
- Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any StageCompletedPhase 3Drugs for Neglected DiseasesNCT03025789Written as Fexinidazole
- Oral Fexinidazole Dosing Regimens for the Treatment of Adults With Chronic Indeterminate Chagas DiseaseCompletedPhase 2Drugs for Neglected DiseasesNCT03587766Written as Fexinidazole
- Efficacy and Safety of Fexinidazole in Patients With Stage 1 or Early Stage 2 Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open-label Cohort Study, plug-in to the Pivotal StudyCompletedPhase 2/3Drugs for Neglected DiseasesNCT02169557Written as Fexinidazole
- Efficacy and Safety of Fexinidazole in Children at Least 6 Years Old and Weighing Over 20 kg With Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open Study, plug-in to the Pivotal StudyCompletedPhase 2/3Drugs for Neglected DiseasesNCT02184689Written as fexinidazole
- Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2CompletedPhase 2/3Drugs for Neglected DiseasesNCT01685827Written as Fexinidazole
- Fexinidazole (1200mg) Bioavailability Under Different Food Intake ConditionsCompletedPhase 1Drugs for Neglected DiseasesNCT01340157Written as Fexinidazole
- Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in SudanTerminatedPhase 2Drugs for Neglected DiseasesNCT01980199Written as Fexinidazole
- Bioequivalence Study - Reference Clinical Fexinidazole Tablet Versus Proposed Market FormulationCompletedPhase 1Drugs for Neglected DiseasesNCT02571062Written as Fexinidazole
- Study to Evaluate Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chagas DiseaseStatus unknownPhase 2Drugs for Neglected DiseasesNCT02498782Written as Fexinidazole
Codes
What other systems call fexinidazole · ClinicalTrials.gg INT003090
- MeSH (NLM) C038307fexinidazoleConfirmed NLM, Wikidata
- UNII (FDA) 306ERL82IRFEXINIDAZOLEConfirmed FDA, NLM, Wikidata
- RxNorm 2564146One source FDA
- Wikidata Q5446115fexinidazoleConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65680FexinidazoleOne source FDA
- DrugBank DB12265One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C038307 | fexinidazole | Confirmed NLM, Wikidata |
| UNII (FDA) | 306ERL82IR | FEXINIDAZOLE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2564146 | — | One source FDA |
| Wikidata | Q5446115 | fexinidazole | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65680 | Fexinidazole | One source FDA |
| DrugBank | DB12265 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.